×
About 3,183 results

ALLMedicine™ Peptic Ulcer Disease Center

Research & Reviews  1,483 results

Helicobacter pylori knowledge and perception among multi-ethnic Asians.
https://doi.org/10.1111/hel.12794
Helicobacter Teng TZJ, Sudharsan M et. al.

Mar 3rd, 2021 - Helicobacter pylori (HP) infection is endemic and causes peptic ulcer disease and gastric cancer. There is a lack of data related to awareness of the general public about HP and associated health risks. The objective of this study was to investiga...

Helicobacter pylori: Commensal, symbiont or pathogen?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901052
World Journal of Gastroenterology; Reshetnyak VI, Burmistrov AI et. al.

Mar 1st, 2021 - This review considers the data on Helicobacter pylori (H. pylori), which have been accumulated over 40 years since its description as an etiological factor in gastrointestinal diseases. The majority of modern publications are devoted to the study ...

Evidence-based clinical practice guidelines for peptic ulcer disease 2020.
https://doi.org/10.1007/s00535-021-01769-0 10.1007/s00535-014-1016-1 10.1111/den.12183 10.1111/den.13184 10.1136/gutjnl-2015-311304 10.1111/apt.13876 10.1136/gutjnl-2017-314010 10.1136/gutjnl-2017-314852 10.7326/0003-4819-152-1-201001050-00179 10.1186/s13017-019-0223-8 10.1055/s-0034-1365235 10.1046/j.1365-2036.2000.00822.x 10.1111/j.1365-2036.2005.02546.x 10.5152/tjg.2018.17143 10.1111/bcp.12866 10.1155/2009/191706 10.1056/NEJMoa1007964 10.3892/etm.2016.3693 10.1093/eurheartj/ehx419 10.1053/j.gastro.2016.08.054 10.1111/hel.12597 10.1111/j.1523-5378.2007.00508.x 10.3389/fphar.2018.01560 10.1136/gutjnl-2016-312288 10.3390/jcm9020543 10.3748/wjg.v21.i2.661 10.1038/ajg.2017.195 10.1038/ajg.2015.439 10.1159/000454762 10.3748/wjg.v23.i4.668 10.2169/internalmedicine.56.7833 10.1007/s00535-012-0731-8 10.1111/jgh.12442 10.1111/hel.12286 10.1007/BF02088227 10.1186/1471-230X-2-17 10.1016/S0149-2918(97)80098-7 10.1007/s40262-015-0326-7 10.1093/rheumatology/32.6.474 10.1001/archinte.160.10.1455 10.1056/NEJM199803123381105 10.1016/S0140-6736(02)07272-0 10.1111/j.1365-2036.2005.02444.x 10.1111/j.1523-5378.2012.00942.x 10.1056/NEJM199605303342204 10.1016/S2468-1253(18)30037-2 10.1016/S1590-8658(00)80402-8 10.1007/s00535-012-0541-z 10.1111/j.1365-2036.2012.05133.x 10.1016/S0140-6736(07)60749-1 10.1053/j.gastro.2014.06.007 10.1186/ar2207 10.1016/S0140-6736(99)02332-6 10.1016/S0016-5085(99)70334-3 10.1093/rheumatology/keg359 10.1111/apt.12174 10.1046/j.1365-2036.2003.01650.x 10.3748/wjg.14.4535 10.1111/apt.13642 10.1038/ajg.2012.87 10.3748/wjg.v21.i17.5382 10.1371/journal.pone.0131558 10.1053/j.gastro.2016.09.006 10.1053/j.gastro.2009.09.063 10.1038/ajg.2011.385 10.1016/j.cgh.2011.05.020 10.1253/circj.CJ-12-0511 10.1016/j.ahj.2011.08.007 10.1056/NEJM200103293441304 10.1056/NEJMoa012877 10.1007/s00535-011-0397-7 10.1007/s00535-012-0588-x 10.1111/apt.12907 10.1136/gutjnl-2013-304722 10.1016/S0140-6736(09)61246-0 10.1111/jgh.12768 10.1136/hrt.2010.217547 10.1053/j.gastro.2004.05.001 10.1016/S0140-6736(07)61909-6 10.1111/j.1365-2036.2006.02912.x 10.1016/j.cgh.2007.06.009 10.1016/S0140-6736(17)30981-9 10.1056/NEJMoa1611593 10.1001/jama.296.13.jrv60011 10.1016/j.clinthera.2004.10.002 10.1111/j.1365-2036.2010.04378.x 10.1136/gut.34.6.762 10.1111/den.12635 10.1053/j.gastro.2009.05.006 10.1136/gutjnl-2019-318715 10.1111/j.1572-0241.1998.00279.x 10.1007/s00268-005-7797-x 10.1097/00000658-200002000-00001 10.1046/j.0007-1323.2001.01831.x 10.1111/j.1523-5378.2011.00928.x 10.1016/j.ijsu.2008.12.001 10.1007/BF01308523 10.1016/S0027-9684(15)31248-7
Journal of Gastroenterology; Kamada T, Satoh K et. al.

Feb 23rd, 2021 - The Japanese Society of Gastroenterology (JSGE) revised the third edition of evidence-based clinical practice guidelines for peptic ulcer disease in 2020 and created an English version. The revised guidelines consist of nine items: epidemiology, h...

Aspirin Is Safe for Venous Thromboembolism Prophylaxis for Patients With a History of G...
https://doi.org/10.1016/j.arth.2021.01.069
The Journal of Arthroplasty; Grosso MJ, Kozaily E et. al.

Feb 21st, 2021 - The safety of acetylsalicylic acid (ASA, aspirin) in patients with prior history of gastroesophageal reflux or peptic ulcer disease remains unclear. The purpose of this study was to determine the safety of ASA for venous thromboembolism (VTE) prop...

GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointe...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895976
Nature Communications; Wu Y, Murray GK et. al.

Feb 20th, 2021 - Genetic factors are recognized to contribute to peptic ulcer disease (PUD) and other gastrointestinal diseases, such as gastro-oesophageal reflux disease (GORD), irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Here, genome-wid...

see more →

Guidelines  11 results

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
https://doi.org/10.1038/ajg.2016.563
The American Journal of Gastroenterology; Chey WD, Leontiadis GI et. al.

Jan 10th, 2017 - Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer. H. pylori may also have a role in uninvestigated and functional dyspepsia, ulcer risk in patients taki...

Treatment of Helicobacter pylori Infection: ACG Guidelines
http://gi.org/guideline/treatment-of-helicobacter-pylori-infection/
Chey WC

Jan 9th, 2017 - Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer.

Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
https://doi.org/10.1007/s00535-016-1166-4
Journal of Gastroenterology; Satoh K, Yoshino J et. al.

Feb 17th, 2016 - The Japanese Society of Gastroenterology (JSGE) revised the evidence-based clinical practice guidelines for peptic ulcer disease in 2014 and has created an English version. The revised guidelines consist of seven items: bleeding gastric and duoden...

Quality indicators for EGD
https://www.asge.org/docs/default-source/education/practice_guidelines/doc-b68366e5-03fd-429d-8150-77193bec8873.pdf?sfvrsn=6
Walter G. Park

Nov 30th, 2014 - EGD is used widely for the diagnosis and treatment of esophageal, gastric, and small-bowel disorders. When properly performed, it is generally safe and well-tolerated for the examination of the upper GI tract.

Management of Patients with Ulcer Bleeding
http://gi.org/guideline/management-of-patients-with-ulcer-bleeding/
Laine, L.,et al

Feb 6th, 2012 - This guideline presents recommendations for the step-wise management of patients with overt upper gastrointestinal bleeding. Hemodynamic status is first assessed, and resuscitation initiated as needed.

see more →

Drugs  4 results see all →

Clinicaltrials.gov  1,571 results

Helicobacter pylori knowledge and perception among multi-ethnic Asians.
https://doi.org/10.1111/hel.12794
Helicobacter Teng TZJ, Sudharsan M et. al.

Mar 3rd, 2021 - Helicobacter pylori (HP) infection is endemic and causes peptic ulcer disease and gastric cancer. There is a lack of data related to awareness of the general public about HP and associated health risks. The objective of this study was to investiga...

Helicobacter pylori: Commensal, symbiont or pathogen?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901052
World Journal of Gastroenterology; Reshetnyak VI, Burmistrov AI et. al.

Mar 1st, 2021 - This review considers the data on Helicobacter pylori (H. pylori), which have been accumulated over 40 years since its description as an etiological factor in gastrointestinal diseases. The majority of modern publications are devoted to the study ...

Evidence-based clinical practice guidelines for peptic ulcer disease 2020.
https://doi.org/10.1007/s00535-021-01769-0 10.1007/s00535-014-1016-1 10.1111/den.12183 10.1111/den.13184 10.1136/gutjnl-2015-311304 10.1111/apt.13876 10.1136/gutjnl-2017-314010 10.1136/gutjnl-2017-314852 10.7326/0003-4819-152-1-201001050-00179 10.1186/s13017-019-0223-8 10.1055/s-0034-1365235 10.1046/j.1365-2036.2000.00822.x 10.1111/j.1365-2036.2005.02546.x 10.5152/tjg.2018.17143 10.1111/bcp.12866 10.1155/2009/191706 10.1056/NEJMoa1007964 10.3892/etm.2016.3693 10.1093/eurheartj/ehx419 10.1053/j.gastro.2016.08.054 10.1111/hel.12597 10.1111/j.1523-5378.2007.00508.x 10.3389/fphar.2018.01560 10.1136/gutjnl-2016-312288 10.3390/jcm9020543 10.3748/wjg.v21.i2.661 10.1038/ajg.2017.195 10.1038/ajg.2015.439 10.1159/000454762 10.3748/wjg.v23.i4.668 10.2169/internalmedicine.56.7833 10.1007/s00535-012-0731-8 10.1111/jgh.12442 10.1111/hel.12286 10.1007/BF02088227 10.1186/1471-230X-2-17 10.1016/S0149-2918(97)80098-7 10.1007/s40262-015-0326-7 10.1093/rheumatology/32.6.474 10.1001/archinte.160.10.1455 10.1056/NEJM199803123381105 10.1016/S0140-6736(02)07272-0 10.1111/j.1365-2036.2005.02444.x 10.1111/j.1523-5378.2012.00942.x 10.1056/NEJM199605303342204 10.1016/S2468-1253(18)30037-2 10.1016/S1590-8658(00)80402-8 10.1007/s00535-012-0541-z 10.1111/j.1365-2036.2012.05133.x 10.1016/S0140-6736(07)60749-1 10.1053/j.gastro.2014.06.007 10.1186/ar2207 10.1016/S0140-6736(99)02332-6 10.1016/S0016-5085(99)70334-3 10.1093/rheumatology/keg359 10.1111/apt.12174 10.1046/j.1365-2036.2003.01650.x 10.3748/wjg.14.4535 10.1111/apt.13642 10.1038/ajg.2012.87 10.3748/wjg.v21.i17.5382 10.1371/journal.pone.0131558 10.1053/j.gastro.2016.09.006 10.1053/j.gastro.2009.09.063 10.1038/ajg.2011.385 10.1016/j.cgh.2011.05.020 10.1253/circj.CJ-12-0511 10.1016/j.ahj.2011.08.007 10.1056/NEJM200103293441304 10.1056/NEJMoa012877 10.1007/s00535-011-0397-7 10.1007/s00535-012-0588-x 10.1111/apt.12907 10.1136/gutjnl-2013-304722 10.1016/S0140-6736(09)61246-0 10.1111/jgh.12768 10.1136/hrt.2010.217547 10.1053/j.gastro.2004.05.001 10.1016/S0140-6736(07)61909-6 10.1111/j.1365-2036.2006.02912.x 10.1016/j.cgh.2007.06.009 10.1016/S0140-6736(17)30981-9 10.1056/NEJMoa1611593 10.1001/jama.296.13.jrv60011 10.1016/j.clinthera.2004.10.002 10.1111/j.1365-2036.2010.04378.x 10.1136/gut.34.6.762 10.1111/den.12635 10.1053/j.gastro.2009.05.006 10.1136/gutjnl-2019-318715 10.1111/j.1572-0241.1998.00279.x 10.1007/s00268-005-7797-x 10.1097/00000658-200002000-00001 10.1046/j.0007-1323.2001.01831.x 10.1111/j.1523-5378.2011.00928.x 10.1016/j.ijsu.2008.12.001 10.1007/BF01308523 10.1016/S0027-9684(15)31248-7
Journal of Gastroenterology; Kamada T, Satoh K et. al.

Feb 23rd, 2021 - The Japanese Society of Gastroenterology (JSGE) revised the third edition of evidence-based clinical practice guidelines for peptic ulcer disease in 2020 and created an English version. The revised guidelines consist of nine items: epidemiology, h...

Aspirin Is Safe for Venous Thromboembolism Prophylaxis for Patients With a History of G...
https://doi.org/10.1016/j.arth.2021.01.069
The Journal of Arthroplasty; Grosso MJ, Kozaily E et. al.

Feb 21st, 2021 - The safety of acetylsalicylic acid (ASA, aspirin) in patients with prior history of gastroesophageal reflux or peptic ulcer disease remains unclear. The purpose of this study was to determine the safety of ASA for venous thromboembolism (VTE) prop...

GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointe...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895976
Nature Communications; Wu Y, Murray GK et. al.

Feb 20th, 2021 - Genetic factors are recognized to contribute to peptic ulcer disease (PUD) and other gastrointestinal diseases, such as gastro-oesophageal reflux disease (GORD), irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Here, genome-wid...

see more →

News  111 results

Large prospective trial offers reassurance for long-term PPI use
https://www.mdedge.com/gihepnews/article/205801/upper-gi-tract/large-prospective-trial-offers-reassurance-long-term-ppi-use/page/0/1?channel=347

Aug 2nd, 2019 - Most patients in the trial (78%) were male, and 23% were current smokers. Smaller proportions of the population were taking an NSAID (5%) and/or had a history of peptic ulcer disease (2.

July 2019 - Question 2
https://www.mdedge.com/gihepnews/article/203785/july-2019-question-2?channel=29259

Jun 28th, 2019 - Q2. Correct answer: C Rationale Oral iron, and not infusions, are associated with peptic ulcer disease.

Can acid suppression prevent recurrent idiopathic gastroduodenal ulcer bleeding?
https://www.mdedge.com/jcomjournal/article/202014/gastroenterology/can-acid-suppression-prevent-recurrent-idiopathic?channel=213
Doug Brunk

May 31st, 2019 - SAN DIEGO – Lansoprazole and famotidine are comparable for the prevention of recurrent ulcer bleeding in patients with a history of Helicobacter pylori–negative idiopathic bleeding ulcers, results from a double-blind, randomized trial showed. Howe.

DDSEP® 8 Quick Quiz Question 2
https://www.mdedge.com/gihepnews/article/197788/ddsepr-8-quick-quiz-question-2

Mar 29th, 2019 - Critique: Factors raising suspicion for Zollinger-Ellison syndrome include recurrent peptic ulcer disease, multiple ulcers, post-bulbar ulcer, non-H. pylori/non-NSAID-related duodenal ulcer, diarrhea, erosive esophagitis, and family or personal hi.

April 2019 - Question 2
https://www.mdedge.com/gihepnews/article/197788/april-2019-question-2?channel=29259

Mar 29th, 2019 - Critique: Factors raising suspicion for Zollinger-Ellison syndrome include recurrent peptic ulcer disease, multiple ulcers, post-bulbar ulcer, non-H. pylori/non-NSAID-related duodenal ulcer, diarrhea, erosive esophagitis, and family or personal hi.

see more →

Patient Education  3 results see all →